| DESCRIPTION |
Microstructured Transdermal Systems (MTS) Microstructured Transdermal Systems enables the disruption of the outermost layer of the skin, the stratum corneum, without causing pain. Several successful development milestones have been achieved with MTS. Co. achieved successful delivery of water soluble, polar, ionic, and large molecules (19,500 dalton) in laboratory testing. MTS expands the range of drugs that can be delivered transdermally and potentially reduces variation in transdermal drug delivery caused by different skin types and application sites. It is suited for vaccines, protein or peptide-based drugs |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |